High Risk of Preterm Delivery
Conditions
Keywords
virtual reality, anxiety, prematurity, pregnancy
Brief summary
Patients at high risk of preterm birth are hospitalized with an high stress for their child's future. In order to better prepare the patient to a possible preterm delivery we use to propose her a visit of the neonatology unit. However, as a result of their obstetrical condition and of the pediatric staff disponibility, this visit is not always possible. Virtual Reality (VR) is well known to provide an immersive experience while staying in a unique place. Our project is to propose a virtual visit of the delivery room, neonatology unit and intensive care unit to all hospitalized patients at risk of preterm delivery in order to prepare and decompress them.
Detailed description
Most of the future parents are unprepared to outcomes of their premature child and the neonatology unit visit has a demonstrated anxiolytic effect on them (decrease of 6.7 points on the State Trait Anxiety Inventory-form Y scale (STAI-Y1)) unfortunately, as a result of their obstetrical condition and of the pediatric staff disponibility, the visit of the neonatology unit is not always possible in time. Furthermore VR is known to be an immersive experience wich had already proved its comforting interest during delivery or to prepare patient to a planned caesarean. In this study we propose to all hospitalized and high risk of delivery early patients a virtual visit of the neonatology unit from their sit in the calm space of their room. If the patient doesn't tolerate or has some VR contraindication : a virtual visit is possible on digital tablet. The visit is presented after the foetal lung maturation by 48h of Betamethasone. Patients complete a STAI-Y-A survey before and after the experience and a Simulator Sickness Questionnaire (SSQ) questionary to evaluate their tolerance. All medical informations can be found in the medical record.
Interventions
OTHERVirtual reality
Virtual reality visit of the birth room, cesarean and pediatric hospitalization department: neonatology and neonatal intensive care
Sponsors
University Hospital, Limoges
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hospitalized patient * Patient with high risk of preterm delivery * \> 24 Week of Gestation (WG) et ≤ 34 WG * Patient who received corticosteroids for fetal lung maturation in the previous 24h * Patient \> 18 years old
Exclusion criteria
* Patient no speak french * no read french * \> 34 WG * Guardianship, curatorship, or under the protection of a conservator * Foetus vital prognosis engaged * Medical contraindication to virtual reality: Epilepsy, bipolarity, severe motion sickness ( evaluated by the patient herself : history of nausea, sweat, emesis during car, boat or airplane transportation … +/- preventive therapy)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Impact of a virtual reality | Day 1 | evaluation of the impact of a virtual reality visit on the anxiety of hospitalized patients with a risk of preterm delivery with the STAI-YA questionary |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of deliveries | Hours 12 | Number of deliveries in the 12 following hours VR. |
| Number of patients experiencing an increase in uterine contractions | Hours 12 | Number of patients experiencing an increase in uterine contractions in the 12 following hours VR. |
| Number of patients with rupture of membranes | Hours 12 | Number of patients with rupture of membranes obstetrical complications in the 12 following hours VR. |
| Evolution of Heart rate kinetics | Day 2 | evolution of heart rate kinetics during VR in beats per minute within 48 hours |
| % of patients with Arterial hypotension | Day 2 | Proportion in % of patients with arterial hypotension within 2 hours after VR in mmHg |
| % of patients with difficulty falling asleep | Day 2 | Proportion in % of patients with difficulty falling asleep the night after the visit, self-reported at the next day's medical visit. |
| Average length of visit in VR | through study completion, a maximum of 18 weeks | Average length of visit for each patient |
| % of patients wtihCybercinetosis | Hours 2 | Individual mean score and number and proportion of patients with an SSQ score \> 38/48 |
| % of patients wtih Visit interruption | Hours 2 | proportion in % of patients who interrupted the visit |
| % of patients wtih Visit on tablet | Hours 2 | Proportion in % of patients who completed the visit on a tablet |
| % of patients wtih Renewal of the visit in VR | through study completion, a maximum of 18 weeks | Proportion in % of patients wishing to repeat the visit |
| overall satisfaction | through study completion, a maximum 18 weeks | Description of the patient's overall satisfaction of this study with Lickert's scale (Score between 0 unnecessary and 10 very useful) |
| Consumption of anxiolytics and analgesics | Day 2 | Variation in the use of anxiolytics and analgesics |
Countries
France
Outcome results
None listed